High-performance liquid chromatography method to analyze free and total urinary pyridinoline and deoxypyridinoline

Analytical Biochemistry

Volumn 318, Issue 2, 2003, Pages 204-211

  Vesper, H W ^a   Audain, C ^a   Woolfitt, A ^a   Ospina, M ^a   Barr, J ^a   Robins, S P ^b   Myers, G L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Deoxypyridinoline; Pyridinoline; Standardization; Synthetic standards

Indexed keywords

BIOCHEMISTRY; CHEMISTRY; STANDARDIZATION;

BONE DISEASE; BONE METABOLISM; BONE RESORPTION; DEOXYPYRIDINOLINE; GOOD CORRELATIONS; INTER-ASSAY VARIABILITY; PYRIDINOLINE; SPECTROSCOPIC CHARACTERISTICS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

DEOXYPYRIDINOLINE; PYRIDINOLINE;

ARTICLE; BONE; CALIBRATOR; CORRELATION ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSTEOLYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; ULTRAVIOLET SPECTROSCOPY; URINALYSIS;

EID: 0038581608     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(03)00241-0     Document Type: Article

References (34)

1. Eyre D.R., Paz M.A., Gallop P.M. Cross-linking in collagen and elastin. Annu. Rev. Biochem. 53:1984;717-748.
2. Demers L.M. Biochemical markers in the management of patients with metastatic bone diseases. Clin. Chem. 45:1999;1131-1132.
3. Delmas P.D., Eastell R., Garnero P., Seibel M.J., Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis Int. 6:2000;S2-S17.
4. Nishizawa Y., Nakamura T., Ohata H., Kushida K., Gorai I., Shiraki M., Fukunaga M., Hosoi T., Miki T., Nakatsuka K., Miura M. Guidelines on the use of biochemical bone markers in osteoporosis. J. Bone Miner. Metab. 19:2001;228-344.
5. Miller P.D., Baran D.T., Bilezikian J.P., Greenspan S.L., Lindsay R., Riggs B.L., Watts N.B. Practical clinical application of biochemical markers of bone turnover: consensus of an expert panel. J. Clin. Densitom. 2:1999;323-342.
6. Souberbielle J.C., Cormier C., Kindermans C. Bone markers in clinical practice. Curr. Opin. Rheumatol. 11:1999;312-319.
7. Robins S.P., Stewart P., Astbury C., Bird H.A. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann. Rheumatic Diseases. 1986;969-973.
8. Fontana A., Delmas P.D. Markers of bone turnover in bone metastases. Cancer. 88:2000;2952-2960.
9. Demers L.M., Costa L., Lipton A. Biochemical markers and skeletal metastases. Cancer. 88:2000;2919-2926.
10. Fed. Register, November 23, 66(226) (2001) 58843-58845.
11. Mariconda M., Pavia M., Colonna A., Angelillo I.F., Marsico O., Sanzo F.et al. Appendicular bone density, biochemical markers of bone turnover and lifestyle factors in female teachers of Southern Italy. Eur. J. Epidemiol. 13:1997;909-917.
12. Matsumoto T., Nakagawa S., Nishida S., Hirota R. Bone density and bone metabolic markers in active collegiate athletes: findings in long-distance runners, judoists, and swimmers. Int. J. Sports Med. 18:1997;408-412.
13. Fiore C.E., Pennisi P., Ciffo F., Scebba C., Amico A., Di Fazzio S. Immobilization-dependent bone collagen breakdown appears to increase with time: evidence for a lack of new bone equilibrium in response to reduced load during prolonged bed rest. Horm. Metab. Res. 31:1999;31-36.
14. New S.A., Robins S.P., Campbell M.K., Martin J.C., Garton M.J., Bolton-Smith C.et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am. J. Clin. Nutr. 71:2000;142-151.
15. James I.T., Walne A.J., Perrett D. The measurement of pyridinium crosslinks: a methodological overview. Ann. Clin. Biochem. 33:1996;397-420.
16. Weitz S.L., Benham P., Leung S.S. Total deoxypyridinoline in serum and urine as measured by a novel adaption of the Pyrilinks-D enzyme immunoassay. J. Bone Mineral Res. 14:1999;S371.
17. Spacek P., Hulejova H., Adam M. Determination of pyridinium crosslinks in serum-an optimization of sample preparation. J. Chromatogr. B. 689:1997;404-408.
18. Robins S.P. Collagen crosslinks in metabolic bone disease. Acta Orthop. Scand. S266:1995;171-175.
19. Blumsohn A., Naylor K.E., Assiri A.M., Eastell R. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin. Chem. 41:1995;1592-1598.
20. Vesper H.W., Smith S.J., Audain C., Myers G.L. Comparison study of urinary pyridinoline and deoxypyridinoline measurements in 13 US laboratories. Clin. Chem. 47:2001;2029-2031.
21. Seibel M.J., Lang M., Geilenkeuser W.J. Interlaboratory variation of biochemical markers of bone turnover. Clin. Chem. 47:2001;1443-1450.
22. Risteli J., Demers L.M., Eastell R., Garnero P., Hoyle N. Committee for markers of bone turnover and bone disease (C-MBTBD). Clin. Chem. Lab. Med. 37:1999;S109-S110.
23. Woloszczuk W. IFCC committee on markers for bone turnover and bone disease-project presentation. Scand. J. Clin. Lab. Invest. 227:1997;95-99.
24. Kent G.N. Standardization of marker assays-pyridinoline/deoxypyridinoline. Scand. J. Clin. Lab. Invest. 227:1997;73-79.
25. Bjellerup P. Standardization of HPLC measurements of pyridinium crosslinks. Scand. J. Clin. Lab. Invest. 227:1997;80-83.
26. Robins S.P., Duncan A., Wilson N., Evans B.J. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin. Chem. 42:1996;1621-1626.
27. Waelchli R., Beerli C., Meigel H., Revesz L. First total synthesis of the bone resorption markers deoxypyridinoline and hydroxypyridinoline. Bioorg. Med. Chem. Lett. 7:1997;2831-2836.
28. Allevi P., Longo A., Anastasia M. Total synthesis of deoxypyridinoline, a biochemical marker of collagen turnover. Chem. Commun. 1999;559-560.
29. Veraart J.R., Kok S.J., te Koppele J.M., Gooijer C., Lingeman H., Velthorst N.H., Brinkman U.A. Capillary electrophoresis of the collagen crosslinks HP and LP utilizing absorbance, wavelength-resolved laser-induced fluorescence and conventional fluorescence detection. Biomed. Chromatogr. 12:1998;226-231.
30. Black D., Duncan A., Robins S.P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal. Biochem. 169:1988;197-203.
31. Pratt D.A., Daniloff Y., Duncan A., Robins S.P. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal. Biochem. 207:1992;168-175.
32. James I.T., Walne A.J., Perrett D. Automated solid-phase extraction with high-performance liquid chromatography analysis of pyridinium crosslinks. Anal. Biochem. 240:1996;29-36.
33. Bank R.A., Beekman B., Verzijl N., De Roos J.A., Sakkee A.N., Tekoppele J.M. Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J. Chromatogr. 1:1997;37-44.
34. Colwell A., Russell R.G., Eastell R. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur. J. Clin. Invest. 23:1993;341-349.